AzTrials
AzTrials

AutismPhase 1/2NCT00378157

Joint Attention Intervention and Young Children With Autism

A Phase 1/2 study testing Joint attention intervention in people with Autism, run by Ullevaal University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effectiveness of an intervention aimed to increase joint attention in 2-4 year old children with autism. The study will be conducted in mainstream preschools in Norway. Read more about this study

Who is it for?
Ages 24 to 60 months
Conditions the study is for
Autism
What is being tested?
Joint attention intervention
How many people
61 participants
Where
1 siteNorway
Study dates
Sep 2006to Jan 2010
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 60 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • diagnosis of autism
  • age 2-4 year old

Who cannot join

  • severe mental retardation
  • severe clinical CNS disorders

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Ullevaal University Hospital

    Oslo, 0319

Other trials in Norway

About this study

Official title: Effectiveness of Joint Attention Intervention in Young Children With Autism - a Randomized Study

The purpose of this study is to investigate the effectiveness of an intervention aimed to increase joint attention in 2-4 year old children with autism. The study will be conducted in mainstream preschools in Norway. The intervention will be implemented by preschool teachers and paraprofessionals supervised by trained counselors.

Read the detailed description

Young children with autism experience severe deficit in joint attention skills (e.g. pointing to objects, showing, following another person's gaze, responding to invitations to social interaction). Ability to initiate and respond to joint attention is linked to children's later language abilities. As a mean to improve language outcome in children with autism, it is important to target joint attention in early intervention programs.

This study investigates the effectiveness of a joint attention intervention. Sixty 2-4 year old children with autism will be randomized to an intervention group or a control group. Children in both groups will continue their ordinary preschool program. However, the children in the intervention group will also participate in 80 joint attention intervention sessions. The sessions (20 minutes each) will be conducted twice a day for 8 weeks by preschool teachers or paraprofessionals working in the preschools. Before starting the intervention preschool teachers and paraprofessionals will be taught how to teach joint attention skills and how to initiate and maintain episodes of joint engagement. During the course of intervention they will be supervised by trained counselors.

Outcome measures will include joint attention skills, language skills and joint engagement. Children will be assessed at baseline, after 10 weeks and at follow up 6 months and 1 year after the end of the intervention. The measures are based on direct testing of the children, video observations and questionnaires to parent and professionals.

Conditions
Autism
Being tested
Joint attention intervention
Keywords
autism, joint attention, intervention, joint engagement, language
Medical subject headings
Autistic Disorder, Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Joint attention interventionBehavioural

    Eight weeks with two daily sessions (20 minutes) with joint attention intervention in the pre-school.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. childrens score on measures of joint attention

    Measured: pre, post, follow up 6 months and 1 year

Secondary outcomes (3)
  1. score on measures of joint engagement -child and mother

    Measured: pre, post, follow up 6 months and 1 year

  2. childrens score on measures of language

    Measured: pre and follow up 1 year

  3. parents and service providers perception of the intervention

    Measured: post, follow up 6 months and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2006 (estimated)
  2. Study startSep 2006
  3. Primary completionDec 2009
  4. Study completionJan 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00378157
Sponsor's protocol ID
UUS 29560105
Status last verified
Feb 2011
First submitted
18 Sep 2006
Last updated
23 Feb 2011
Results posted
No

Publications

  • Kaale A, Fagerland MW, Martinsen EW, Smith L. Preschool-based social communication treatment for children with autism: 12-month follow-up of a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):188-98. doi: 10.1016/j.jaac.2013.09.019. Epub 2013 Oct 17.

    PubMed 24472253
  • Kaale A, Smith L, Sponheim E. A randomized controlled trial of preschool-based joint attention intervention for children with autism. J Child Psychol Psychiatry. 2012 Jan;53(1):97-105. doi: 10.1111/j.1469-7610.2011.02450.x. Epub 2011 Aug 30.

    PubMed 21883204

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Joint attention intervention in people with Autism, run by Ullevaal University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

childrens score on measures of joint attention (time frame: pre, post, follow up 6 months and 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00378157, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in